Global CRISPR Gene Detection and Diagnostic Market Research Report 2024

Report ID: 1981242 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Cutting Function Detection Method
        1.2.3 Positioning Function Detection Method
    1.3 Market by Application
        1.3.1 Global CRISPR Gene Detection and Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global CRISPR Gene Detection and Diagnostic Market Perspective (2017-2028)
    2.2 CRISPR Gene Detection and Diagnostic Growth Trends by Region
        2.2.1 CRISPR Gene Detection and Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 CRISPR Gene Detection and Diagnostic Historic Market Size by Region (2017-2022)
        2.2.3 CRISPR Gene Detection and Diagnostic Forecasted Market Size by Region (2023-2028)
    2.3 CRISPR Gene Detection and Diagnostic Market Dynamics
        2.3.1 CRISPR Gene Detection and Diagnostic Industry Trends
        2.3.2 CRISPR Gene Detection and Diagnostic Market Drivers
        2.3.3 CRISPR Gene Detection and Diagnostic Market Challenges
        2.3.4 CRISPR Gene Detection and Diagnostic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top CRISPR Gene Detection and Diagnostic Players by Revenue
        3.1.1 Global Top CRISPR Gene Detection and Diagnostic Players by Revenue (2017-2022)
        3.1.2 Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Players (2017-2022)
    3.2 Global CRISPR Gene Detection and Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by CRISPR Gene Detection and Diagnostic Revenue
    3.4 Global CRISPR Gene Detection and Diagnostic Market Concentration Ratio
        3.4.1 Global CRISPR Gene Detection and Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CRISPR Gene Detection and Diagnostic Revenue in 2021
    3.5 CRISPR Gene Detection and Diagnostic Key Players Head office and Area Served
    3.6 Key Players CRISPR Gene Detection and Diagnostic Product Solution and Service
    3.7 Date of Enter into CRISPR Gene Detection and Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Gene Detection and Diagnostic Breakdown Data by Type
    4.1 Global CRISPR Gene Detection and Diagnostic Historic Market Size by Type (2017-2022)
    4.2 Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Type (2023-2028)
5 CRISPR Gene Detection and Diagnostic Breakdown Data by Application
    5.1 Global CRISPR Gene Detection and Diagnostic Historic Market Size by Application (2017-2022)
    5.2 Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America CRISPR Gene Detection and Diagnostic Market Size (2017-2028)
    6.2 North America CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022)
    6.3 North America CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe CRISPR Gene Detection and Diagnostic Market Size (2017-2028)
    7.2 Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022)
    7.3 Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size (2017-2028)
    8.2 Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022)
    8.3 Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America CRISPR Gene Detection and Diagnostic Market Size (2017-2028)
    9.2 Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022)
    9.3 Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size (2017-2028)
    10.2 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022)
    10.3 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Roche Molecular Diagnostics
        11.1.1 Roche Molecular Diagnostics Company Detail
        11.1.2 Roche Molecular Diagnostics Business Overview
        11.1.3 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Introduction
        11.1.4 Roche Molecular Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.1.5 Roche Molecular Diagnostics Recent Development
    11.2 Sherlock Biosciences
        11.2.1 Sherlock Biosciences Company Detail
        11.2.2 Sherlock Biosciences Business Overview
        11.2.3 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Introduction
        11.2.4 Sherlock Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.2.5 Sherlock Biosciences Recent Development
    11.3 Thermo Fisher Scientific Inc.
        11.3.1 Thermo Fisher Scientific Inc. Company Detail
        11.3.2 Thermo Fisher Scientific Inc. Business Overview
        11.3.3 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Introduction
        11.3.4 Thermo Fisher Scientific Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.3.5 Thermo Fisher Scientific Inc. Recent Development
    11.4 Aelian Biotechnology
        11.4.1 Aelian Biotechnology Company Detail
        11.4.2 Aelian Biotechnology Business Overview
        11.4.3 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Introduction
        11.4.4 Aelian Biotechnology Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.4.5 Aelian Biotechnology Recent Development
    11.5 Vivlion
        11.5.1 Vivlion Company Detail
        11.5.2 Vivlion Business Overview
        11.5.3 Vivlion CRISPR Gene Detection and Diagnostic Introduction
        11.5.4 Vivlion Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.5.5 Vivlion Recent Development
    11.6 Beckman Coulter Diagnostics
        11.6.1 Beckman Coulter Diagnostics Company Detail
        11.6.2 Beckman Coulter Diagnostics Business Overview
        11.6.3 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Introduction
        11.6.4 Beckman Coulter Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.6.5 Beckman Coulter Diagnostics Recent Development
    11.7 Binx Health
        11.7.1 Binx Health Company Detail
        11.7.2 Binx Health Business Overview
        11.7.3 Binx Health CRISPR Gene Detection and Diagnostic Introduction
        11.7.4 Binx Health Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.7.5 Binx Health Recent Development
    11.8 bioMérieux Diagnostics
        11.8.1 bioMérieux Diagnostics Company Detail
        11.8.2 bioMérieux Diagnostics Business Overview
        11.8.3 bioMérieux Diagnostics CRISPR Gene Detection and Diagnostic Introduction
        11.8.4 bioMérieux Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.8.5 bioMérieux Diagnostics Recent Development
    11.9 Caspr Biotech
        11.9.1 Caspr Biotech Company Detail
        11.9.2 Caspr Biotech Business Overview
        11.9.3 Caspr Biotech CRISPR Gene Detection and Diagnostic Introduction
        11.9.4 Caspr Biotech Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.9.5 Caspr Biotech Recent Development
    11.10 Agilent
        11.10.1 Agilent Company Detail
        11.10.2 Agilent Business Overview
        11.10.3 Agilent CRISPR Gene Detection and Diagnostic Introduction
        11.10.4 Agilent Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.10.5 Agilent Recent Development
    11.11 Axxam
        11.11.1 Axxam Company Detail
        11.11.2 Axxam Business Overview
        11.11.3 Axxam CRISPR Gene Detection and Diagnostic Introduction
        11.11.4 Axxam Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.11.5 Axxam Recent Development
    11.12 ERS Genomics
        11.12.1 ERS Genomics Company Detail
        11.12.2 ERS Genomics Business Overview
        11.12.3 ERS Genomics CRISPR Gene Detection and Diagnostic Introduction
        11.12.4 ERS Genomics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.12.5 ERS Genomics Recent Development
    11.13 FASMAC
        11.13.1 FASMAC Company Detail
        11.13.2 FASMAC Business Overview
        11.13.3 FASMAC CRISPR Gene Detection and Diagnostic Introduction
        11.13.4 FASMAC Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.13.5 FASMAC Recent Development
    11.14 Illumina
        11.14.1 Illumina Company Detail
        11.14.2 Illumina Business Overview
        11.14.3 Illumina CRISPR Gene Detection and Diagnostic Introduction
        11.14.4 Illumina Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.14.5 Illumina Recent Development
    11.15 Janssen Diagnostics
        11.15.1 Janssen Diagnostics Company Detail
        11.15.2 Janssen Diagnostics Business Overview
        11.15.3 Janssen Diagnostics CRISPR Gene Detection and Diagnostic Introduction
        11.15.4 Janssen Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.15.5 Janssen Diagnostics Recent Development
    11.16 Locus Biosciences
        11.16.1 Locus Biosciences Company Detail
        11.16.2 Locus Biosciences Business Overview
        11.16.3 Locus Biosciences CRISPR Gene Detection and Diagnostic Introduction
        11.16.4 Locus Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.16.5 Locus Biosciences Recent Development
    11.17 Mammoth Biosciences
        11.17.1 Mammoth Biosciences Company Detail
        11.17.2 Mammoth Biosciences Business Overview
        11.17.3 Mammoth Biosciences CRISPR Gene Detection and Diagnostic Introduction
        11.17.4 Mammoth Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.17.5 Mammoth Biosciences Recent Development
    11.18 NRGene
        11.18.1 NRGene Company Detail
        11.18.2 NRGene Business Overview
        11.18.3 NRGene CRISPR Gene Detection and Diagnostic Introduction
        11.18.4 NRGene Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.18.5 NRGene Recent Development
    11.19 Bio-Rad Laboratories, Inc
        11.19.1 Bio-Rad Laboratories, Inc Company Detail
        11.19.2 Bio-Rad Laboratories, Inc Business Overview
        11.19.3 Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Introduction
        11.19.4 Bio-Rad Laboratories, Inc Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.19.5 Bio-Rad Laboratories, Inc Recent Development
    11.20 10x Genomics, Inc.
        11.20.1 10x Genomics, Inc. Company Detail
        11.20.2 10x Genomics, Inc. Business Overview
        11.20.3 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Introduction
        11.20.4 10x Genomics, Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022)
        11.20.5 10x Genomics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Cutting Function Detection Method
    Table 3. Key Players of Positioning Function Detection Method
    Table 4. Global CRISPR Gene Detection and Diagnostic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global CRISPR Gene Detection and Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global CRISPR Gene Detection and Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global CRISPR Gene Detection and Diagnostic Market Share by Region (2017-2022)
    Table 8. Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global CRISPR Gene Detection and Diagnostic Market Share by Region (2023-2028)
    Table 10. CRISPR Gene Detection and Diagnostic Market Trends
    Table 11. CRISPR Gene Detection and Diagnostic Market Drivers
    Table 12. CRISPR Gene Detection and Diagnostic Market Challenges
    Table 13. CRISPR Gene Detection and Diagnostic Market Restraints
    Table 14. Global CRISPR Gene Detection and Diagnostic Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global CRISPR Gene Detection and Diagnostic Market Share by Players (2017-2022)
    Table 16. Global Top CRISPR Gene Detection and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Detection and Diagnostic as of 2021)
    Table 17. Ranking of Global Top CRISPR Gene Detection and Diagnostic Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by CRISPR Gene Detection and Diagnostic Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players CRISPR Gene Detection and Diagnostic Product Solution and Service
    Table 21. Date of Enter into CRISPR Gene Detection and Diagnostic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global CRISPR Gene Detection and Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Type (2017-2022)
    Table 25. Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Type (2023-2028)
    Table 27. Global CRISPR Gene Detection and Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Application (2017-2022)
    Table 29. Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Application (2023-2028)
    Table 31. North America CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Roche Molecular Diagnostics Company Detail
    Table 42. Roche Molecular Diagnostics Business Overview
    Table 43. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Product
    Table 44. Roche Molecular Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 45. Roche Molecular Diagnostics Recent Development
    Table 46. Sherlock Biosciences Company Detail
    Table 47. Sherlock Biosciences Business Overview
    Table 48. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Product
    Table 49. Sherlock Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 50. Sherlock Biosciences Recent Development
    Table 51. Thermo Fisher Scientific Inc. Company Detail
    Table 52. Thermo Fisher Scientific Inc. Business Overview
    Table 53. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Product
    Table 54. Thermo Fisher Scientific Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 55. Thermo Fisher Scientific Inc. Recent Development
    Table 56. Aelian Biotechnology Company Detail
    Table 57. Aelian Biotechnology Business Overview
    Table 58. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Product
    Table 59. Aelian Biotechnology Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 60. Aelian Biotechnology Recent Development
    Table 61. Vivlion Company Detail
    Table 62. Vivlion Business Overview
    Table 63. Vivlion CRISPR Gene Detection and Diagnostic Product
    Table 64. Vivlion Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 65. Vivlion Recent Development
    Table 66. Beckman Coulter Diagnostics Company Detail
    Table 67. Beckman Coulter Diagnostics Business Overview
    Table 68. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Product
    Table 69. Beckman Coulter Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 70. Beckman Coulter Diagnostics Recent Development
    Table 71. Binx Health Company Detail
    Table 72. Binx Health Business Overview
    Table 73. Binx Health CRISPR Gene Detection and Diagnostic Product
    Table 74. Binx Health Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 75. Binx Health Recent Development
    Table 76. bioMérieux Diagnostics Company Detail
    Table 77. bioMérieux Diagnostics Business Overview
    Table 78. bioMérieux Diagnostics CRISPR Gene Detection and Diagnostic Product
    Table 79. bioMérieux Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 80. bioMérieux Diagnostics Recent Development
    Table 81. Caspr Biotech Company Detail
    Table 82. Caspr Biotech Business Overview
    Table 83. Caspr Biotech CRISPR Gene Detection and Diagnostic Product
    Table 84. Caspr Biotech Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 85. Caspr Biotech Recent Development
    Table 86. Agilent Company Detail
    Table 87. Agilent Business Overview
    Table 88. Agilent CRISPR Gene Detection and Diagnostic Product
    Table 89. Agilent Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 90. Agilent Recent Development
    Table 91. Axxam Company Detail
    Table 92. Axxam Business Overview
    Table 93. Axxam CRISPR Gene Detection and DiagnosticProduct
    Table 94. Axxam Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 95. Axxam Recent Development
    Table 96. ERS Genomics Company Detail
    Table 97. ERS Genomics Business Overview
    Table 98. ERS Genomics CRISPR Gene Detection and DiagnosticProduct
    Table 99. ERS Genomics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 100. ERS Genomics Recent Development
    Table 101. FASMAC Company Detail
    Table 102. FASMAC Business Overview
    Table 103. FASMAC CRISPR Gene Detection and DiagnosticProduct
    Table 104. FASMAC Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 105. FASMAC Recent Development
    Table 106. Illumina Company Detail
    Table 107. Illumina Business Overview
    Table 108. Illumina CRISPR Gene Detection and DiagnosticProduct
    Table 109. Illumina Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 110. Illumina Recent Development
    Table 111. Janssen Diagnostics Company Detail
    Table 112. Janssen Diagnostics Business Overview
    Table 113. Janssen Diagnostics CRISPR Gene Detection and DiagnosticProduct
    Table 114. Janssen Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 115. Janssen Diagnostics Recent Development
    Table 116. Locus Biosciences Company Detail
    Table 117. Locus Biosciences Business Overview
    Table 118. Locus Biosciences CRISPR Gene Detection and DiagnosticProduct
    Table 119. Locus Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 120. Locus Biosciences Recent Development
    Table 121. Mammoth Biosciences Company Detail
    Table 122. Mammoth Biosciences Business Overview
    Table 123. Mammoth Biosciences CRISPR Gene Detection and DiagnosticProduct
    Table 124. Mammoth Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 125. Mammoth Biosciences Recent Development
    Table 126. NRGene Company Detail
    Table 127. NRGene Business Overview
    Table 128. NRGene CRISPR Gene Detection and DiagnosticProduct
    Table 129. NRGene Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 130. NRGene Recent Development
    Table 131. Bio-Rad Laboratories, Inc Company Detail
    Table 132. Bio-Rad Laboratories, Inc Business Overview
    Table 133. Bio-Rad Laboratories, Inc CRISPR Gene Detection and DiagnosticProduct
    Table 134. Bio-Rad Laboratories, Inc Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 135. Bio-Rad Laboratories, Inc Recent Development
    Table 136. 10x Genomics, Inc. Company Detail
    Table 137. 10x Genomics, Inc. Business Overview
    Table 138. 10x Genomics, Inc. CRISPR Gene Detection and DiagnosticProduct
    Table 139. 10x Genomics, Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2017-2022) & (US$ Million)
    Table 140. 10x Genomics, Inc. Recent Development
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CRISPR Gene Detection and Diagnostic Market Share by Type: 2021 VS 2028
    Figure 2. Cutting Function Detection Method Features
    Figure 3. Positioning Function Detection Method Features
    Figure 4. Global CRISPR Gene Detection and Diagnostic Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Others Case Studies
    Figure 8. CRISPR Gene Detection and Diagnostic Report Years Considered
    Figure 9. Global CRISPR Gene Detection and Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global CRISPR Gene Detection and Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global CRISPR Gene Detection and Diagnostic Market Share by Region: 2021 VS 2028
    Figure 12. Global CRISPR Gene Detection and Diagnostic Market Share by Players in 2021
    Figure 13. Global Top CRISPR Gene Detection and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Detection and Diagnostic as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by CRISPR Gene Detection and Diagnostic Revenue in 2021
    Figure 15. North America CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America CRISPR Gene Detection and Diagnostic Market Share by Country (2017-2028)
    Figure 17. United States CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe CRISPR Gene Detection and Diagnostic Market Share by Country (2017-2028)
    Figure 21. Germany CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Share by Region (2017-2028)
    Figure 29. China CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America CRISPR Gene Detection and Diagnostic Market Share by Country (2017-2028)
    Figure 37. Mexico CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Share by Country (2017-2028)
    Figure 41. Turkey CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Roche Molecular Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 44. Sherlock Biosciences Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 45. Thermo Fisher Scientific Inc. Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 46. Aelian Biotechnology Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 47. Vivlion Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 48. Beckman Coulter Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 49. Binx Health Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 50. bioMérieux Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 51. Caspr Biotech Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 52. Agilent Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 53. Axxam Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 54. ERS Genomics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 55. FASMAC Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 56. Illumina Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 57. Janssen Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 58. Locus Biosciences Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 59. Mammoth Biosciences Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 60. NRGene Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 61. Bio-Rad Laboratories, Inc Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 62. 10x Genomics, Inc. Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Molecular Diagnostics
Sherlock Biosciences
Thermo Fisher Scientific Inc.
Aelian Biotechnology
Vivlion
Beckman Coulter Diagnostics
Binx Health
bioMérieux Diagnostics
Caspr Biotech
Agilent
Axxam
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Bio-Rad Laboratories, Inc
10x Genomics, Inc.
Frequently Asked Questions
CRISPR Gene Detection and Diagnostic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CRISPR Gene Detection and Diagnostic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CRISPR Gene Detection and Diagnostic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports